Rejuve Health Introduces: World-Class Gene Therapy
Today we’re making history and you’re invited to be apart of it.
Rejuve is the first clinic in the U.S. to procure and offer Follistatin Gene Therapy.
What is Follistatin Gene Therapy?
Follistatin (FST) is a leading longevity gene therapy shown to be safe, well-researched, and effective in reversing key aging markers such as inflammation, fat accumulation, and epigenetic age. Human trials and animal studies have demonstrated its ability to increase lean mass, extend lifespan, and address age-related issues like frailty and obesity, making it a promising candidate for anti-aging interventions.
Follistation (FST) is premier gene therapy that increases telomere length and muscle mass WHILE decreasing body fat & epigenetic age.
Benefits:
Increased Muscle Mass: An average of 2 pounds of muscle was reported, but was noted to be up to 12 pounds in some patients.
Increased Telomere Length: Significant lengthening of telomeres.
Decreased Epigentic Age: An average of 7 years of epigenetic improvements noted after one year of therapy.
Decreased Body Fat: Average of 1% reduction noted after one month with the largest decrease of 3.8%.
Increased Bone Density: Exceptional improvement in lumbar spine, and hip density.
Experience the life changing benefits of gene therapy today.
DUE TO EXCLUSIVITY & CLINICAL OVERSIGHT - SECURE YOUR PERSONALIZED EXPERIENCE.